KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Prepaid Assets (2016 - 2025)

Emergent BioSolutions' Prepaid Assets history spans 16 years, with the latest figure at $25.8 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 4.09% year-over-year to $25.8 million; the TTM value through Dec 2025 reached $25.8 million, down 4.09%, while the annual FY2025 figure was $25.8 million, 4.09% down from the prior year.
  • Prepaid Assets reached $25.8 million in Q4 2025 per EBS's latest filing, up from $25.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $139.9 million in Q3 2022 to a low of $24.0 million in Q2 2025.
  • Average Prepaid Assets over 5 years is $56.7 million, with a median of $46.3 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: surged 105.92% in 2021, then crashed 64.35% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $70.2 million in 2021, then fell by 17.52% to $57.9 million in 2022, then fell by 17.27% to $47.9 million in 2023, then crashed by 43.84% to $26.9 million in 2024, then dropped by 4.09% to $25.8 million in 2025.
  • Per Business Quant, the three most recent readings for EBS's Prepaid Assets are $25.8 million (Q4 2025), $25.6 million (Q3 2025), and $24.0 million (Q2 2025).